fig6

From: Efficacy and safety of stereotactic body radiation therapy combined with transarterial chemoembolization for Chinese intermediate-to advanced-stage hepatocellular carcinoma patients: a systematic review and meta-analysis

Efficacy and safety of stereotactic body radiation therapy combined with transarterial chemoembolization for Chinese intermediate-to advanced-stage hepatocellular carcinoma patients: a systematic review and meta-analysis

Figure 6. Meta-analysis of the negative conversion rate of AFP in 6 studies comparing transarterial chemoembolization (TACE) plus stereotactic body radiation therapy (SBRT) with TACE or SBRT monotherapy for intermediate-to advanced-stage hepatocellular carcinoma patients

Hepatoma Research

ISSN 2454-2520 (Online) 2394-5079 (Print)

editorialoffice@hrjournal.net

Navigation

Sitemap